GLP-1 agonists, such as tirzepatide, and SGLT2 inhibitors, as empagliflozin, cause side effects, including nausea, vomiting, abdominal pain, and an increased risk of pancreatitis for GLP-1 agonists [16]. The gene discussed is GCG; the disease is pancreatitis.